Popular Posts
-
Smoking and Cancer Risks Beyond Lung Cancer
Sep 15 2025
July 2025 – What We Covered This Month
Wondering what you might have missed in July? We rolled out a batch of practical drug guides, dosage cheat‑sheets, and the latest on radiopharmaceuticals. If you’re looking for clear, evidence‑based info that you can trust, you’re in the right place.
New Drug Monographs and Dosage Overviews
We added three detailed monographs this month: a deep dive into the anticoagulant apixaban, a side‑effect focused look at the migraine drug ubrogepant, and an easy‑to‑read guide on the diabetes medicine tirzepatide. Each entry breaks down how the drug works, typical dosing schedules, and when you might need to adjust the dose. For instance, the apixaban guide highlights dose reductions for patients with kidney impairment—something many prescribers overlook.
Alongside the monographs, we published two dosage cheat‑sheets. One covers pediatric dosing for common antibiotics, and the other tackles adult dose adjustments for heart failure therapies. Both sheets are formatted as quick‑reference tables, so you can glance at them during a busy clinic shift.
Side‑Effect Breakdowns and Interaction Alerts
Side effects can be the difference between a patient staying on therapy or quitting. Our July side‑effect roundup focuses on three hot topics: the skin reactions associated with the new class of SGLT2 inhibitors, the GI upset linked to oral antivirals for COVID‑19, and the rare but serious pulmonary toxicity seen with some immunotherapies. Each write‑up includes real‑world frequency numbers and practical tips for monitoring.
Interaction alerts are another area we sharpened. We released an interactive chart that maps out common interactions between antidepressants and over‑the‑counter cold medicines. The chart flags what to avoid, what needs dose tweaking, and which combos are generally safe. We also highlighted a newly published study that found a significant interaction between the cholesterol drug ezetimibe and certain probiotics—something you won’t find in most drug databases.
Radiopharmaceutical News You Can Use
Radiopharma is moving fast, and July brought a couple of notable updates. First, we summarised the FDA approval of a new PET tracer for early Alzheimer’s detection. The article explains how the tracer works, who qualifies for imaging, and what the result means for treatment planning.
Second, we explored the clinical rollout of a theranostic agent that combines diagnosis and therapy for neuroendocrine tumors. Our guide walks you through the dosing protocol, safety monitoring, and how to interpret the imaging results. Both pieces aim to cut through the jargon and give you actionable insights.
All of these resources are designed to save you time and boost confidence when you’re prescribing or counseling patients. Bookmark this archive page to revisit any article, and feel free to swing by our blog for updates throughout the year. Got a question about a specific drug or interaction? Drop us a comment and we’ll add it to the next round of posts.
Shepherd's Purse Supplements: Natural Healing for Blood, Skin & Hormones
- By : Tamsin Riverton
- Date : Jul 30 2025
Discover how shepherd's purse supplements work, their key health benefits, safety tips, and how to choose quality products for optimal natural healing.
Horsetail Supplement: Boost Hair, Skin & Nail Health Naturally
- By : Tamsin Riverton
- Date : Jul 29 2025
Discover how horsetail, a silica‑rich herb, can enhance hair, skin, and nail health. Learn the science, dosage, safety, and how it stacks up against other popular supplements.
Dapagliflozin History: From Discovery to FDA Approval
- By : Tamsin Riverton
- Date : Jul 25 2025
Explore the full journey of dapagliflozin, from early laboratory research through clinical trials to its 2014 FDA approval, highlighting key players and breakthrough data.